Excision repair cross-complementing rodent repair deficiency complementation group 2/xeroderma pigmentosum group D (ERCC2/XPD) plays a crucial role in the etiology of colorectal cancer (CRC) [8]. This evidence concerns the gene ERCC2 and colorectal carcinoma.